Commentary
It is time for the government in partnership with industry to return to the drawing board to craft a plan that will provide protection for the more than 9 million people who will need care for dementia by 2040, writes Michael D. Hurd.
Commentary
At the rate that the U.S. population is aging, the total cost of dementia could reach half a trillion dollars a year by 2040. Those who care for impaired relatives and friends are acutely aware of the effects of dementia, and unfortunately they are all too familiar with its costs, writes Kathleen J. Mullen.
Journal Article
The monetary cost of dementia in the United States ranges from $157 billion to $215 billion annually, making the disease more costly to the nation than either heart disease or cancer. The greatest cost is associated with providing institutional and home-based long-term care rather than medical services.
News Release
Head-to-head trials of competing autism treatments are needed to identify which programs are superior and additional work should follow study participants long-term to further examine the effectiveness of treatments.
Journal Article
Head-to-head trials of competing autism treatments are needed to identify which programs are superior and additional work should follow study participants long-term to further examine the effectiveness of treatments.
Journal Article
Many states have implemented regulations (commonly referred to as waivers) to increase access to publicly insured services for autism spectrum disorders (ASD).
Journal Article
This commentary presents an overview of the issues associated with how health plans and public Medicaid systems should share in the costs of assessing and treating children with autism.
Commentary
This year's seasonal flu shot incorporates vaccine for H1N1. It's safe, and it's vitally important to get it, write Art Kellermann and Katherine Harris.
Journal Article
Although amygdala and frontal lobe functional abnormalities have been reported in patients with mood disorders, the literature regarding major depressive disorder (MDD) is inconsistent.
Journal Article
This pilot study suggests that a practice-based intervention can increase referral to Alzheimer's Association chapters and improve quality of dementia care.
Journal Article
Reviews evidence on psychosocial interventions for non-professional careers of people with Parkinson's disease. Most studies were not designed to assess the clinical- or cost-effectiveness of the intervention for the careers.
Journal Article
Responsiveness of this HRQOL measure can be reported in terms of previously established benchmarks for ESs, which can be predicted from other indices.
Journal Article
In this study, HRQOL improvement occurred primarily among patients who achieved complete seizure freedom.
Journal Article
Use of statin cholesterol-lowering drugs is observationally associated with lower rates of Alzheimer disease (AD).
Journal Article
Epilepsy-targeted health-related quality of life measures may be preferable to generic ones in longitudinal studies.
Journal Article
Outcomes in 248 patients who had diagnostic evaluations for epilepsy surgery
Journal Article
Describes the development of a 99-item epilepsy HRQOL inventory that includes the SF-36 as its core.
Journal Article
Agreement between self reports and proxy reports of quality of life in epilepsy patients
Journal Article
Development of quality of life measures de novo is time-consuming and expensive, and a number of instruments are already available for general use.
RAND® is a registered trademark. Copyright © 1994-2013 RAND Corporation. Last Modified: September 15, 2010 Site Feedback »